Insulin Aspart (Novolog) Injectable U-100, U-200 Suppliers & Bulk Manufacturers
Available Forms: Vials/pens
Available Strengths: U-100, U-200
Reference Brands: Novolog, Fiasp(US &EU)
Category: Diabetes
Insulin aspart is a rapid-acting insulin injected just before meals in type 1 and type 2 diabetes, available in vials, cartridges and pens (100 units/ml). The originator products are NovoRapid/NovoLog and the faster-acting Fiasp; a biosimilar insulin aspart has been approved in the US since 2025. Cold chain at 2–8 °C is required. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.
Manufacture or export Insulin Aspart (Novolog) Injectable? List it or send an offer →
Product Description:
Insulin Aspart (Novolog) is a rapid-acting insulin approved in the EU and US for controlling blood glucose during meals. In the EU, Novo Nordisk’s Novolog and Fiasp are regulated by the EMA, with dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, the FDA has approved NovoLog and Fiasp based on comprehensive clinical data and biosimilarity studies, ensuring quality and consistency. Both regions require detailed regulatory dossiers and ongoing pharmacovigilance for safety monitoring.
Insulin Aspart (Novolog) Injectable — third party manufacturing & bulk supply
Insulin Aspart (Novolog) Injectable U-100, U-200 is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Insulin Aspart (Novolog) Injectable is supplied as Vials/pens — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Insulin Aspart (Novolog) Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Insulin Aspart (Novolog) Injectable →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Insulin Aspart is used to improve blood sugar control in patients with diabetes mellitus, including both type 1 and type 2 diabetes. It helps regulate glucose levels by allowing sugar to enter cells where it is used for energy.
Insulin Aspart is a rapid-acting recombinant insulin analog produced using biotechnology. It is structurally modified from human insulin to allow faster absorption and quicker onset of action.
Common trade names include NovoLog, NovoRapid, Fiasp, and Trurapi.
The original insulin aspart products NovoLog and NovoRapid were developed and marketed by the pharmaceutical company Novo Nordisk, while other pharmaceutical companies manufacture biosimilar versions.
The generic name is Insulin Aspart.
Common brand names include NovoLog, NovoRapid, Fiasp, and Trurapi.
Insulin Aspart is manufactured in several countries including Denmark, the United States, and other regions by different pharmaceutical manufacturers.
Immediately before meals (0–10 minutes), or Fiasp up to 20 minutes after starting a meal.
10 ml vials, 3 ml Penfill cartridges, FlexPen/FlexTouch pens and PumpCart cartridges for insulin pumps.
Unopened at 2–8 °C; in use at room temperature for up to 4 weeks.
Related Products
Insulin Glargine (Lantus) Injectable
Strength:
U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details
Insulin Lispro (Humalog) Injectable
Strength:
U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View Details
Regular Insulin (Human) Injectable
Strength:
U-100 (100 units/mL)
Form: Vials/pens
Reference Brands: Humulin R, Novolin R, Admelog R(US); Actrapid, Humulin R, Monotard R(EU)
View Details
Premixed Insulins (70/30, 50/50) Injectable
Strength:
U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View Details
Alogliptin / Pioglitazone Tablet
Strength:
12.5 mg / 30 mg, 25 mg / 15 mg, 25 mg / 30 mg, 25 mg / 45 mg
Form: Tablets
Reference Brands: Oseni (USA), Incresync(EU)
View Details
Diazoxide
Strength:
25 mg, 50 mg, 50 mg/mL
Form: Tablets / Capsule / Oral suspension
Reference Brands: Proglycem (USA/EU), Eudemine (EU)
View Details
Glyburide
Strength:
1.25 mg, 2.5 mg, 5 mg
Form: Tablets
Reference Brands: Diabeta (USA), Micronase (USA), Glynase PresTab (USA)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
